DAISY
Live / Applied — Ex parte appeal pending (as of 04 Nov 2025)
What this means for you
Not registered yet, but its 12 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98354562
- Mark type
- Stylized text
- Filed
- 12 Jan 2024
- Attorney of record
- MARK E. TETREAULT
Goods and services
- Class 005 — Pharmaceuticals: Disposable intradermal injectors sold pre-filled with medication, namely vaccines.
- Class 009 — Scientific and electric apparatus: Disposable intradermal injectors for laboratory use
- Class 010 — Medical apparatus: Disposable intradermal injectors for medical purposes sold empty; disposable intradermal injectors for vaccines sold empty; disposable intradermal injectors for pharmaceuticals sold empty; medical devices in the nature of intradermal injection devices for administering drugs, vaccines, and therapeutic agents sold empty.
Owner
- DEKA Research & Development Corp., Manchester, NH, US
Prosecution history
- 19 Mar 2026 — EX PARTE APPEAL-REFUSAL AFFIRMED
- 04 Nov 2025 — NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
- 04 Nov 2025 — EXAMINERS STATEMENT E-MAILED
- 04 Nov 2025 — EXAMINERS STATEMENT - COMPLETED
- 11 Sept 2025 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 11 Aug 2025 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 25 Jul 2025 — NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
- 25 Jul 2025 — ACTION DENYING REQ FOR RECON E-MAILED
- 25 Jul 2025 — ACTION CONTINUING FINAL - COMPLETED
- 15 Jul 2025 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 16 May 2025 — EX PARTE APPEAL-INSTITUTED
- 16 May 2025 — EXPARTE APPEAL RECEIVED AT TTAB
- 19 Feb 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 19 Feb 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 22 Nov 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED